Market Overview

35 Stocks Moving In Monday's Mid-Day Session

Share:

Gainers

  • American Electric Technologies, Inc (NASDAQ: AETI) shares jumped 135.2 percent to $1.74 after the company’s M&I Electric business announced a $14 million project with a leading Engineering, Procurement and Construction firm.
  • BIO-key International, Inc. (NASDAQ: BKYI) surged 34.5 percent to $3.00. BIO-key International disclosed that it has completed conversion of all outstanding preferred stock into common stock at a conversion price of $3.60 per share.
  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) shares rose 24.6 percent to $32.285 after the company reported updated interim Phase 1 clinical study results with DCC-2618 at the ASCO Annual Meeting.
  • Highpower International Inc (NASDAQ: HPJ) shares gained 15.9 percent to $3.332.
  • CSS Industries, Inc. (NYSE: CSS) climbed 11.5 percent to $18.035. DA Davidson upgraded CSS Industries from Neutral to Buy.
  • Denali Therapeutics Inc. (NASDAQ: DNLI) rose 10.8 percent to $20.88.
  • Immunomedics, Inc. (NASDAQ: IMMU) shares climbed 10.2 percent to $25.02. Clovis Oncology and Immunomedics reported a planned clinical collaboration to study combination therapies in metastatic triple-negative breast and urothelial cancers.
  • China Natural Resources, Inc. (NASDAQ: CHNR) rose 10.1 percent to $2.69.
  • Genomic Health, Inc. (NASDAQ: GHDX) shares climbed 10 percent to $43.6652 after the company disclosed that the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, successfully defined the benefit of chemotherapy in early-stage breast cancer patients with Oncotype DX Breast Recurrence Score® results of 11 to 25.
  • Evolus, Inc. (NASDAQ: EOLS) climbed 7.4 percent to $29.31.
  • Petróleo Brasileiro S.A. - Petrobras (NYSE: PBRA) shares gained 7.1 percent to $9.165.
  • PFSweb, Inc. (NASDAQ: PFSW) gained 7.1 percent to $11.6776.
  • Digital Ally, Inc. (NASDAQ: DGLY) rose 4 percent to $2.75 after the company reported that the US Patent Office has denied Axon's request to invalidate a Digital Ally patent.

Check out these big penny stock gainers and losers

Losers

  • Nektar Therapeutics (NASDAQ: NKTR) shares dipped 41.3 percent to $52.9990. Nektar and Bristol-Myers Squibb reported preliminary data for NKTR-214 in combination with opdivo for patients with Stage IV metastatic melanoma, renal cell carcinoma, and urothelial cancers.
  • Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 37.4 percent to $7.015 after the company presented preliminary data from its ongoing Phase 1/2 ICONIC trial of JTX-2011 in patients with advanced solid tumors.
  • Daqo New Energy Corp. (NYSE: DQ) shares fell 21.2 percent to $41.56 after dropping 8.57 percent on Friday.
  • Vaxart, Inc. (NASDAQ: VXRT) dropped 17.9 percent to $4.304 as the company disclosed that its Phase 2 trial of teslexivir did not meet its primary endpoint.
  • Gevo, Inc. (NASDAQ: GEVO) dipped 16.1 percent to $4.03.
  • Blueprint Medicines Corporation (NASDAQ: BPMC) shares fell 14.8 percent to $72.00. Blueprint Medicines and CStone Pharmaceuticals reported a partnership and license agreement to develop and commercialize Avapritinib, BLU-554 and BLU-667 in Greater China.
  • Amtech Systems, Inc. (NASDAQ: ASYS) tumbled 14.8 percent to $8.45.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) fell 14.1 percent to $13.00 after dropping 14.07 percent on Friday.
  • PPDAI Group Inc. (NYSE: PPDF) fell 13.4 percent to $6.66.
  • Zymeworks Inc. (NYSE: ZYME) dropped 13 percent to $19.0132.
  • G1 Therapeutics, Inc. (NASDAQ: GTHX) shares dipped 13 percent to $37.95 after the company presented Phase 1b data on G1T38 in combination with faslodex for treatment of breast cancer at the ASCO 2018.
  • Co-Diagnostics, Inc. (NASDAQ: CODX) fell 12.3 percent to $4.20 after climbing 65.17 percent on Friday.
  • Moxian, Inc. (NASDAQ: MOXC) shares declined 10.8 percent to $1.91.
  • NovoCure Limited (NASDAQ: NVCR) dropped 10.3 percent to $28.675. Novocure will present INNOVATE-3 Phase 3 pivotal trial design in recurrent ovarian cancer at the ASCO Annual Meeting 2018.
  • ChemoCentryx, Inc. (NASDAQ: CCXI) fell 9.5 percent to $11.73.
  • Viking Therapeutics, Inc. (NASDAQ: VKTX) dropped 8.5 percent to $8.9191 after falling 2.40 percent on Friday. Viking Therapeutics shares more than doubled Thursday after a 145-percent jump in shares of Madrigal Pharmaceuticals, which announced data from a Phase 2 study of its non-alcoholic steatohepatitis pipeline candidate.
  • CRISPR Therapeutics AG (NASDAQ: CRSP) fell 7.9 percent to $61.850 after declining 2.58 percent on Friday.
  • Enphase Energy, Inc. (NASDAQ: ENPH) dropped 7.4 percent to $5.35. Enphase Energy named Eric Branderiz as Vice President and Chief Financial Officer.
  • Tactile Systems Technology, Inc. (NASDAQ: TCMD) slipped 6.6 percent to $47.10. BTIG Research downgraded Tactile Systems Technology from Buy to Neutral.
  • Colfax Corporation (NYSE: CFX) fell 6.1 percent to $28.89. Bank of America downgraded Colfax from Buy to Underperform.
  • The Trade Desk, Inc. (NASDAQ: TTD) dropped 5.9 percent to $81.505. Wells Fargo downgraded Trade Desk from Outperform to Market Perform.
  • Viper Energy Partners LP (NASDAQ: VNOM) fell 5.3 percent to $28.80. Stifel Nicolaus downgraded Viper Energy Partners from Buy to Hold.

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

 

Related Articles (AETI + ASYS)

View Comments and Join the Discussion!

Auto Pair Trade: Goldman Sachs Buys Toyota, Steps To Sidelines On Honda

Luxoft's Risk-Reward Improving, But Credit Suisse Says It's Neutral Until Evidence Of Growth Emerges